GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,002 | -30.6% | 74,407 | +0.7% | 0.00% | – |
| Q2 2023 | $406,423 | +26.7% | 73,895 | -0.9% | 0.00% | – |
| Q1 2023 | $320,780 | +389.3% | 74,600 | +347.2% | 0.00% | – |
| Q4 2022 | $65,564 | -26.3% | 16,683 | -0.1% | 0.00% | – |
| Q3 2022 | $89,000 | -19.1% | 16,696 | +0.5% | 0.00% | – |
| Q2 2022 | $110,000 | -22.0% | 16,621 | -13.3% | 0.00% | – |
| Q1 2022 | $141,000 | +4.4% | 19,176 | +1.2% | 0.00% | – |
| Q4 2021 | $135,000 | -74.1% | 18,950 | -8.7% | 0.00% | – |
| Q3 2021 | $521,000 | +9.5% | 20,761 | +17.3% | 0.00% | – |
| Q2 2021 | $476,000 | – | 17,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |